Click on the coloured blocks below to see the roles and teammembers of each expertise that are part of EHEG.


R. Finkenflugel
0 team members


C. Rokx
0 team members


0 team members


B. Koch
0 team members


P. Katsikis
0 team members

Biochemistry, Pathology

We are fundamental scientists that investigate the molecular mechanisms that contribute to HIV latency and develop tools to characterize and quantitate the replication competent reservoir in PLWHIV. Using both candidate approaches and unbiased screens we identify novel druggable molecular targets for pharmacological intervention, which we characterize mechanistically and functionally in vitro models of HIV latency and in cells obtained from c-ART suppressed PLWHIV. We also use unbiased approaches to identify candidate new drugs, focusing on FDA/EMA approved novel therapeutics, for HIV latency reversal and induction of cell death in re-actiactivated cells, which we mechanistically and functionally characterize in various in vitro models of latency.We then test the effectiveness of putative novel candidate therapeutics to eliminate the reservoir ex vivo in cells obtained from PLWHIV study volunteers using various assays that probe the reservoir at the DNA level, at the transcriptional and translational competent levels. 


Our current team members

Click on a picture of one of our teammembers to see their personalia

Team members who have worked for EHEG in the past



Why I like working for EHEG

Personal goals:



Want to become part of this team?


Fill out the form and we will contact you as soon as possible to talk over the possibilities of you joing our team. 

You can try contacting us directly via: